Source comparison
Comparison: Key Mitochondrial-Derived Peptides for Research
Understanding MOTS-c in context means looking at other mitochondrial-derived peptides (MDPs) that are also garnering significant research attention in 2026. Each has unique properties and research applications, though they often share common ground in influenc
This comparison does not assign a generated winner or score.
- Understanding MOTS-c in context means looking at other mitochondrial-derived peptides (MDPs) that are also garnering significant research attention in 2026. Each has unique properties and research applications, though they often share common ground in influencing cellular metabolism and mitochondrial function. Here's what we've seen in our labs and through our collaborations:
- MOTS-c
- Metabolic health, longevity, exercise
- AMPK activation, mitochondrial biogenesis
- Insulin sensitivity, physical endurance, anti-aging
- Humanin
- Neuroprotection, anti-apoptotic
- Protects cells from stress, inhibits apoptosis
- Alzheimer's research, stroke recovery
- SS-31 (Elamipretide)
- Mitochondrial dysfunction, oxidative stress
- Targets inner mitochondrial membrane, reduces ROS
- Renal ischemia, heart failure, mitochondrial diseases
- SHLP2
- Metabolic regulation, cellular proliferation
- Influences glucose/lipid metabolism, cell growth
- Cancer research, metabolic disorders
- This table isn't exhaustive, of course, but it gives you a sense of the diverse and compelling landscape of MDP research that's flourishing in 2026. Researchers often choose between these based on their specific hypothesis and the particular cellular or systemic outcome they're aiming to investigate. For a truly comprehensive approach, sometimes combining these powerful tools is the most insightful path.